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Abstract
Background. Depression frequently co-occurs with disorders of glucose and insulin homeo-
stasis (DGIH) and obesity. Low-grade systemic inflammation and lifestyle factors in childhood
may predispose to DGIH, obesity and depression. We aim to investigate the cross-sectional
and longitudinal associations among DGIH, obesity and depression, and to examine the effect
of demographics, lifestyle factors and antecedent low-grade inflammation on such associations
in young people.
Methods. Using the Avon Longitudinal Study of Parents and Children birth cohort, we used
regression analyses to examine: (1) cross-sectional and (2) longitudinal associations between
measures of DGIH [insulin resistance (IR); impaired glucose tolerance] and body mass index
(BMI) at ages 9 and 18 years, and depression (depressive symptoms and depressive episode)
at age 18 years and (3) whether sociodemographics, lifestyle factors or inflammation [interleu-
kin-6 (IL-6) at age 9 years] confounded any such associations.
Results. We included 3208 participants. At age 18 years, IR and BMI were positively associated
with depression. These associations may be explained by sociodemographic and lifestyle factors.
There were no longitudinal associations between DGIH/BMI and depression, and adjustment
for IL-6 and C-reactive protein did not attenuate associations between IR/BMI and depression;
however, the longitudinal analyses may have been underpowered.
Conclusions. Young people with depression show evidence of DGIH and raised BMI, which
may be related to sociodemographic and lifestyle effects such as deprivation, smoking, ethni-
city and gender. In future, studies with larger samples are required to confirm this.
Preventative strategies for the poorer physical health outcomes associated with depression
should focus on malleable lifestyle factors.
Introduction
Depression in 10–24 year olds is a leading cause of disease burden throughout the world (Gore
et al., 2011). An important aspect of this burden is the co-occurrence of disorders of glucose
and insulin homeostasis (DGIH) [type-2 diabetes mellitus (T2DM) and prediabetes] and obes-
ity (Roy and Lloyd, 2012; Vancampfort et al., 2016). This may be a consequence of
disease-related factors such as symptomatology [e.g. appetite disturbance and decreased phys-
ical activity (Lysy et al., 2008; Vancampfort et al., 2017)], increased rates of smoking (Katon
et al., 2004), alcohol use (Tann et al., 2007), an unhealthy diet (Firth et al., 2018) and also
sociodemographic risk factors such as either male (Nichols and Brown, 2003; Ali et al.,
2006; Ding et al., 2006; Timonen et al., 2006; Perreault et al., 2008; Menke et al., 2014) or
female (Anderson et al., 2001; Blazer et al., 2002; Nichols and Brown, 2003; Ali et al., 2006;
Lloyd et al., 2018) sex, non-white European race/ethnic group (Blazer et al., 2002; Li et al.,
2008; Dagenais et al., 2016; Mangurian et al., 2018) and lower social class or adversity
(Everson et al., 2002; Tamayo et al., 2010; Pisto et al., 2014).
Another postulated mechanism is that depression, DGIH and obesity are intrinsically
linked beyond the above via common antecedent inflammatory processes. Raised interleukin-6
(IL-6) and tumour necrosis factor alpha are antecedent to insulin resistance (IR) (Pickup,
2004; Belgardt et al., 2010), and subsequently T2DM and obesity (DeFronzo and
Ferrannini, 1991; Dandona et al., 2004; Rader, 2007). A recent genome-wide association
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study (Milaneschi et al., 2017) found that common genetic var-
iants for body mass index (BMI) and C-reactive protein (CRP)
show overlap with gene variants associated with depression. In
addition, inflammation may be prospectively linked to depression
in young people, with longitudinal cohort-based research finding
raised levels of IL-6 during childhood to be associated with future
depressive symptoms and diagnosis of depression at age 18 years,
which persisted after controlling for BMI, social class, and child-
hood psychological and behavioural problems preceding IL-6
measurement (Khandaker et al., 2014; Khandaker et al., 2018a,
2018b). This may relate to antecedent stressful events (Slopen
et al., 2013). A recent large meta-analysis has added to these find-
ings, with cytokines including IL-6 marked as part of a potential
chemokine/cytokine profile associated with depression (Köhler
et al., 2017).
The finding that low-grade systemic inflammation appears ante-
cedent to DGIH, obesity and depression may be evidence of a com-
monbiological pathway that begins with an inflammatory response.
Research examining the association among DGIH, obesity and
depression, particularly longitudinally, in a sample of relatively
young people who are less affected by years of illness, is scarce. It
is nonetheless an important extension of the current literature as
the findings may promote earlier and closer monitoring of meta-
bolic and inflammatory function in young people with depression.
It may in addition further our pathophysiological understanding of
the multi-systemic nature of depression and suggest possible pre-
ventative therapeutic targets (Insel and Charney, 2003).
Using longitudinal population-based data, we tested the hypoth-
esis that even relatively young people with depression may display
early signs of DGIH or obesity. We tested cross-sectional (age 18
years) and longitudinal (age 9 and 18 years) associations among
DGIH, obesity and depression. We hypothesised that early signs
of DGIH might be explained by shared inflammatory processes,
or demographic/lifestyle factors. We tested this by assessing for
any attenuation (confounding) effect of either demographic, life-
style or inflammatory measures on associations among DGIH,
obesity and depression.
Methods
Description of cohort and sample selection
The Avon Longitudinal Study of Parents and Children (ALSPAC)
birth cohort (Boyd et al., 2013; Fraser et al., 2013) comprises 14
062 live births from mothers residing in (former) Avon County,
southwest England, with expected dates of delivery between
April 1991 and December 1992. Please note that the study website
contains details of all the data that are available through a fully
searchable data dictionary and variable search tool (http://www.
bristol.ac.uk/alspac/researchers/our-data/). Parents completed
regular postal questionnaires about all aspects of their child’s
health and development from birth. From age 7 years, the chil-
dren attended an annual assessment clinic during which they par-
ticipated in various face-to-face interviews and physical tests. In
an attempt to boost study numbers, further phases of recruitment
took place after the age of 7 years, leading to an additional 713
participants recruited by age 18.
We first selected all participants with a measure for the out-
come (n = 4563) and removed participants with CRP > 10
(Khandaker et al., 2014), to minimise the potential confounding
effect of ongoing or recent inflammatory disease/infection on
our results, leaving 3208 participants. For cross-sectional analyses,
2231 participants had complete data on all exposure and con-
founder variables. For longitudinal analyses, 331 participants
had complete data on all exposure and confounder variables.
The lower sample with complete data for longitudinal analyses
is explained by age 9 glycaemic data being derived from a smaller
ALSPAC sub-study (Ong et al., 2004). Complete-case analysis is
presented in online Supplementary Tables 1 and 2. See statistical
methods for our means of addressing missing data.
The study received ethics approval from the ALSPAC Ethics
and Law Committee and local research ethics committees. All
participants provided written informed consent.
Outcome measures
Depressive symptoms/episode at age 18 years
Depression was measured using the Clinical Interview Schedule-
Revised (CIS-R), a widely used standardised self-assessment tool
for measuring depression and anxiety in community samples
(Lewis et al., 1992). It includes symptoms of depression based
on International Statistical Classification of Diseases, 10th
Revision (ICD-10) criteria, and gives a total depression score of
0–21 comprising symptom scores for depression, depressive
thoughts, fatigue, concentration and sleep problems. Our primary
outcome measure was the continuous CIS-R depression score
(Khandaker et al., 2014). As a secondary outcome, we created a
binary variable ‘depressive episode’. This consisted of participants
meeting ICD-10 criteria for a depressive episode (mild/moderate/
severe) (F32.0/F32.1/F32.2), as has been used previously (Bowes
et al., 2015; Davies et al., 2016; Quarini et al., 2016).
Exposures
Fasting plasma glucose, fasting insulin, glucose tolerance
We used the biochemical measurements of fasting plasma glucose
(FPG) and fasting insulin (FI) (ages 9 and 18 years), and 2-h glucose
tolerance (2hrGT) (age 9 years). The age 9 glycaemic data were
derived from a smaller ‘Before Breakfast Study’ sub-study (Ong
et al., 2004). At both ages 9 and 18 years, fasting samples were
taken at 0900 after a 10-h fast (water only). The 2hrGT test was
obtained following the above fasting procedure, with the addition
of a 75 g oral bolus of sugary syrup at 0900, with blood being sampled
2 h later. Blood sampleswere immediately spunand frozenat−80 °C.
IR was calculated as a continuous measure from FPG and FI by
using the computerised, updated version of the homoeostatic
measurement for insulin resistance (HOMA2) (Levy et al.,
1998). The algorithm generates a relatively precise measurement
of IR taking into account variations in hepatic and peripheral glu-
cose resistance, increases in the insulin secretion curve for plasma
glucose concentrations above 10 mmol/L (180 mg/dL) and the
contribution of circulating proinsulin (Levy et al., 1998). We did
not include a binary measure for clinical IR due to the known
variation in HOMA2 score between populations (Wallace et al.,
2004) thus ascertaining a clinical ‘cut-off’ may be problematic.
BMI
BMI was calculated from clinic data in the ALSPAC cohort, from
measurements of height (m) and weight (kg). We used data col-
lected at ages 9 and 18 years.
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Demographic confounders
We adjusted for paternal social class at birth (questionnaire data,
categorical) and maternal education (questionnaire data, categor-
ical) as proxies of participant social class and potential adversity,
sex (clinic data, categorical), ethnicity (questionnaire data, cat-
egorical) and maternal Edinburgh Post-Natal Depression Score
(EPDS) at 8-week post-partum (questionnaire data, continuous).
Lifestyle confounders
For analyses on DGIH we adjusted for BMI (clinic data, continuous,
ages 9 and18years asper the exposure), smoking (questionnaire data,
categorical), cortisol levels [age 9 only, continuous, clinic data from
BBS sub-study (Ong et al., 2004)], physical activity (questionnaire
data on average frequency of physical activity/exercise per week in
the last year, categorical) and alcohol use (questionnaire data on aver-
age frequency of use, categorical). For BMI analyses, we used the
same adjustments, however with HOMA2 (as previously described,
continuous) in place of BMI.
Inflammatory confounders
We adjusted for IL-6 (age 9 years) and CRP (age 18 years). IL-6
was not available at age 18 years. Blood samples were collected
from non-fasting participants (age 9 years), and fasting partici-
pants (age 18 years) and were immediately spun and frozen at
−80 °C. IL-6 was measured by enzyme-linked immunosorbent
assay (R&D Systems), and high-sensitivity CRP (hs-CRP) was
measured by automated particle-enhanced immunoturbidimetric
assay (Roche). All inter-assay coefficients of variation were less
than 5%.
Statistical analysis
Biomarker values that were non-normally distributed (all except
for FPG) were natural log-transformed. Resultant variables,
alongside the continuous outcome ‘total depression score’ were
standardised (Z-transformed) so the statistical estimations
represent the increase in risk of depressive symptoms per S.D.
increase in exposure. We completed tests for multi-collinearity
of exposures/confounders in a linear regression model. The vari-
ance inflation factor for all covariates was between 1.01 and 1.11,
suggesting minimal multi-collinearity. Adjustments were added
using the enter method of multiple regression. All statistical ana-
lysis was performed using IBM SPSS 24.0.
Aims 1 and 2: cross-sectional and longitudinal relationships
between DGIH/BMI (ages 9 and 18 years) and depression (age
18 years)
We completed cross-sectional linear and logistic regression ana-
lyses which examined the relationship between markers of
DGIH/BMI and depressive symptoms/depressive episode (age
18 years). We completed longitudinal linear and logistic regres-
sion analyses which examined the relationship between markers
of DGIH/BMI (age 9 years) and depressive symptoms/episode
(age 18 years). Regression coefficients and 95% confidence inter-
vals (95% CIs) were calculated per S.D. increase in the continuous
‘total depression score’ outcome, per s.d. increase in exposure,
using linear regression. Odds ratios (ORs) and 95% CIs for the
categorical depressive episode outcome, per S.D. increase in expos-
ure, were estimated using logistic regression. Quadratic terms were
created separately for all exposures and entered into a logistic
regression model to simulate curvilinear regression, to test the lin-
earity of relationships between exposures and depression; these
data are only shown where there was evidence of a non-linear
relationship.
Aim 3: adjusting for demographic factors, lifestyle factors and
inflammation
We performed adjustments using linear and logistic regression as
described above. First, we adjusted for the demographic, lifestyle
and inflammation factors listed above, separately. Second, we
completed a total adjustment model including all potential con-
founders together.
Missing data
Missing data for exposures and confounders were present in 30% of
cases for cross-sectional analyses, and 90% of cases for longitudinal
analyses. Due to the substantial amount of missing data in longitu-
dinal analyses [which may be related to the age 9 glycaemic data
being derived from a smaller ALSPAC sub-study (Ong et al.,
2004)], we longitudinally analysed only complete cases (Lee and
Huber, 2011). For our cross-sectional analyses, Little’s Missing
Completely at Random (MCAR) test ( p = 0.008) indicated that the
data were not MCAR.We then used the missing value analysis func-
tion of SPSS to perform separate variance independent t tests (con-
tinuous variables) and χ2 tests (categorical variables) to check the
missing at random (MAR) assumption. Each variable returned sig-
nificance ( p < 0.05) with at least one other included variable, indicat-
ing that missingness was correlated with another variable in the
model, suggesting the missing data met the MAR assumption.
We completed multiple imputation (MI) using the fully condi-
tional Markov chain Monte Carlo method, for all exposure and
confounder variables, plus axillary continuous variables that
were indicators of missingness in the population. The selected
axillary variables included age 9 biochemical data (high-density
lipoprotein, low-density lipoprotein, triglycerides), as well as
birthweight and gestational age. As missing data were present in
30% of cases, we used 30 imputations as recommended (White
et al., 2011). Complete case analysis for the cross-sectional ana-
lyses is presented in online Supplementary Tables 1 and 2.
Results
Following imputation for exposure and confounder variables, our
total sample was 3208 participants. The mean depression score in
the imputed sample was 3.09; range 0–21 (complete cases 3.10;
range 0–21). The number of participants meeting criteria for a
depressive episode at age 18 was n = 227 (7%) (complete cases
n = 179; 8%). Table 1 shows the sample clinical and biomarker
characteristics at age 18.
Aim 1: cross-sectional association between DGIH/BMI and
depression (age 18 years)
In the unadjusted analyses; HOMA2, FI and BMI were positively
associated with depressive symptoms at age 18 years [β = 0.04
(95% CI 0.03–0.30) p = 0.02; β = 0.05 (95% CI 0.03–0.33) p =
0.01; β = 0.03 (95% CI 0.01–0.08) p = 0.04 respectively]; FPG
was negatively associated with depressive symptoms [β =−0.05
(95% CI −0.36 to −0.02) p = 0.01]. See Table 2. The results
from our complete case analysis were broadly similar. See online
Supplementary Table 1.
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In the unadjusted analyses, both HOMA2 and FI were asso-
ciated with the categorical depressive episode [OR 1.14 (95% CI
1.01–1.31) p = 0.04 and OR 1.16 (95% CI 1.01–1.33) p = 0.03
respectively]. See Table 3. The results are similar to those for
our complete case analysis. See online Supplementary Table 2.
Aim 2: longitudinal association between DGIH/BMI (age 9
years) and depressive symptoms/episode (age 18 years)
Our longitudinal analysis of DGIH included 399 participants, and
for BMI 2571 participants. There were no evident longitudinal
associations between DGIH/BMI at age 9 years and depressive
symptoms/episode at age 18. See Tables 4 and 5.
Aim 3: adjusting for confounders
As shown in Tables 2–5, after adjustments for demographic and
lifestyle factors the point estimates did not change considerably
but the 95% CIs widened to include the null. Adjustment for
immune markers did not significantly alter the unadjusted asso-
ciations. Following adjustment for all confounder variables in
one model, there were no significant associations. Results from
the complete case analysis are broadly similar. See online
Supplementary Tables 1 and 2.
Discussion
In this study, we first tested the cross-sectional associations
between DGIH/BMI and depression in a sample of young people
who may have been less affected by years of illness, before and
after adjustments for potential demographic, lifestyle and immune
confounders. We then used longitudinal analysis to test the direc-
tion of association between these factors. To our knowledge, this
is one of the first analyses of detailed longitudinal associations
among DGIH, BMI, inflammation and depression, in a relatively
young sample, albeit the sample size for some of the analyses was
relatively small. We present several findings of note.
We found that the broadest marker of glycaemic function,
FPG, was negatively associated with depressive symptoms at age
18 years. In addition, more sensitive markers of pre-clinical glu-
cose dysregulation (FI, HOMA2) were positively associated with
depression at age 18 years. IR in combination with low FPG
shows biological plausibility; FPG can present low-normal in
early IR, in response to the IR phenotype of increased insulin
secretion thus increased intracellular glucose uptake (Ensling
Table 1. Baseline characteristics of sample
Characteristic All sample
Depressive
episode
No depressive
episode Test statistica p-value
Participants, n (% total) 3208 (100) 227 (7) 2981 (93) –
Male sex, n (column %) 1553 (48) 62 (27) 1491 (50) 9.167; p = 0.002
Smoking at 18 years, n (column %) (current) 231 (10) 27 (11) 220 (7) 7.535; p = 0.006
Maternal EPDS scoreb, mean (S.D.) 5.89 (4.65) 5.78 (4.65) 5.98 (4.69) 0.476 p = 0.322
Maternal education (A-levels or above), n (column %) 1116 (35) 74 (33) 1049 (35) 0.267 p = 0.096
Alcohol usec (greater than once per week), n (column %) 1320 (41) 132 (58) 1070 (36) 8.756 p = 0.024
Physical activityd (greater than once per week), n (column %) 2213 (69) 78 (35) 2337 (78) 9.967 p < 0.001
Father’s social class, n (column %) 4.235; p = 0.055
I 186 (6) 15 (7) 184 (6)
II 1119 (35) 73 (32) 1077 (36)
III – non-manual 1257 (39) 87 (38) 1145 (38)
III – manual 96 (3) 7 (3) 85 (3)
IV 465 (14) 36 (16) 394 (13)
V 95 (3) 9 (4) 96 (3)
White British ethnicity, n (column %) 3143 (98) 221 (97) 3175 (99) 0.243; p = 0.588
BMI at 18 years, mean (S.D.), kg/m2 22.68 (3.81) 23.06 (5.38) 22.65 (3.79) 8.141; p = 0.330
BMI at 9 years, mean (S.D.), kg/m2 17.54 (2.53) 17.88 (2.23) 17.51 (2.46) 1.967; p = 0.223
FPG at 18 years, mean (S.D.), mmol/L 5.04 (0.59) 4.95 (0.76) 5.09 (0.48) 0.044; p = 0.389
HOMA2 at 18 years, mean (S.D.) 0.92 (0.73) 1.32 (0.55) 0.87 (0.44) 3.860; p = 0.035
CRP at 18 years, mean (S.D.), mg/L 1.11 (1.41) 1.20 (1.05) 1.08 (1.43) 0.423; p = 0.701
IL-6 at 9 years, mean (S.D.), pg/mL 1.21 (0.78) 1.27 (1.58) 1.18 (1.52) 7.687; p = 0.004
CRP at 9 years, mean (S.D.), pg/mL 0.68 (2.52) 0.76 (1.92) 0.65 (3.54) 4.723; p = 0.226
aCategorical variables (sex, social class, ethnicity, smoking) were compared using the χ2 test, normally distributed continuous variables (FPG, birthweight, gestational age) were compared
using the two tailed t test; non-normally distributed continuous variables (HOMA2, CRP, IL-6, BMI) were compared using the Mann–Whitney U test.
bMaternal EPDS score recorded at 8 week post-partum.
cFrequency participant has had drinks containing alcohol.
dPhysical activity corresponded to frequency respondent engaged in going to gym, brisk walking or any sports activity during the past year
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Table 2. Cross-sectional association between DGIH/BMI and depressive symptoms (age 18)
Predictor
Regression coefficient (95% CI) for depressive symptoms
Adjustments
Unadjusted model
Demographic adjustments
(sex, birth social class,
ethnicity, maternal
education, maternal EPDS
score)
Lifestyle adjustments
(BMIa, HOMA2
b, smoking,
alcohol use physical activity)
Immune adjustments
[IL-6 (9 years), CRP (18 years)]
Complete model
(all adjustments)
Depressive
symptoms n β (95% CI) p β (95% CI) p β (95% CI) p β (95% CI) p β (95% CI) p
HOMA2 3208 0.04 (0.02–0.30) 0.023* 0.05 (−0.07–0.21) 0.336 0.04 (−0.09 to 0.18) 0.100 0.04 (0.01–0.31) 0.031* 0.03 (−0.01 to 0.18) 0.638
FPG 3208 −0.05 (−0.36 to −0.02) 0.014* −0.02 (−0.17–0.13) 0.816 −0.04 (−0.30 to 0.07) 0.067 −0.04 (−0.32 to −0.02) 0.021* −0.04 (−0.18 to 0.11) 0.636
Fasting insulin 3208 0.05 (0.03–0.33) 0.013* 0.06 (−0.06–0.13) 0.282 0.05 (−0.02 to 0.12) 0.059 0.04 (0.01–0.17) 0.023* 0.05 (−0.11 to 0.20) 0.553
BMI 3208 0.03 (0.01–0.08) 0.046* 0.03 (−0.01–0.07) 0.144 0.03 (−0.01 to 0.07) 0.062 0.03 (0.01–0.09) 0.031* 0.02 (−0.02 to 0.06) 0.240
aNot adjusted for in BMI analysis.
bNot adjusted for in HOMA/FPG/FI analysis.
*Indicates p < 0.05.
Table 3. Cross-sectional associations between DGIH/BMI and depressive episode (age 18 years)
Predictor
Odds ratio (95% CI) for depressive episode
Adjustments
Depressive
episode
Unadjusted model
Demographic adjustments
(sex, birth social class,
ethnicity, maternal
education, maternal EPDS
score)
Lifestyle adjustments
(BMIa, HOMA2
b, smoking,
alcohol use, physical
activity)
Immune adjustments
[IL-6 (9 years), CRP (18
years)]
Complete model
(all adjustments)
N
outcome n OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
HOMA2 227 3208 1.14 (1.01–1.31) 0.047* 1.07 (0.97–1.24) 0.296 1.12 (0.97–1.30) 0.132 1.15 (1.01–1.32) 0.042* 1.05 (0.91–1.23) 0.498
FPG 227 3208 0.90 (0.77–1.05) 0.174 1.02 (0.88–1.18) 0.787 0.89 (0.76–1.03) 0.115 0.89 (0.77–1.05) 0.165 1.00 (0.87–1.17) 0.959
FI 227 3208 1.16 (1.01–1.33) 0.034* 1.09 (0.94–1.25) 0.269 1.13 (0.98–1.32) 0.098 1.16 (1.02–1.34) 0.029* 1.06 (0.91–1.24) 0.794
BMI 227 3208 1.02 (0.99–1.06) 0.138 1.02 (0.98–1.05) 0.305 1.01 (0.98–1.05) 0.486 1.03 (0.99–1.07) 0.107 1.02 (0.98–1.06) 0.368
aNot adjusted for in BMI analysis.
bNot adjusted for in HOMA/FPG/FI analysis.
*Indicates p < 0.05.
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Table 4. Longitudinal association between DGIH/BMI (age 9) and depressive symptoms (age 18 years)
Predictor
Regression co-efficient (95% CI) for depressive symptoms (age 18 years)
Adjustments
Unadjusted model
Demographic adjustments
(sex, birth social class,
ethnicity, maternal education,
maternal EPDS score)
Lifestyle adjustments
(BMIa, HOMA2
b, physical
activity)
Immune adjustments
[IL-6 (9 years)]
Complete model
(all adjustments)
Depressive symptoms
(18 years) n β (95% CI) p β (95% CI) p β (95% CI) p β (95% CI) p β (95% CI) p
2hrGT (age 9 years) 399 0.07 (−0.33 to 0.34) 0.172 0.01 (−0.36 to 0.37) 0.980 0.06 (−0.26 to 0.46) 0.563 0.04 (−0.26 to 0.23) 0.595 0.01 (−0.36 to 0.37) 0.980
HOMA2 (age 9 years) 399 0.02 (−0.28 to 0.39) 0.739 0.01 (−0.24 to 0.27) 0.917 0.01 (−0.25 to 0.27) 0.954 0.01 (−0.25 to 0.27) 0.942 0.01 (−0.25 to 0.26) 0.972
FPG (age 9 years) 399 0.02 (−0.28 to 0.39) 0.750 0.03 (−0.31 to 0.44) 0.878 0.02 (−0.14 to 0.44) 0.270 0.02 (−0.15 to 0.44) 0.276 0.02 (−0.28 to 0.40) 0.801
FI (age 9 years) 399 0.07 (−0.10 to 0.57) 0.172 0.05 (−0.21 to 0.19) 0.768 0.01 (−0.25 to 0.26) 0.992 0.01 (−0.24 to 0.27) 0.928 −0.01 (−0.25 to 0.24) 0.949
BMI (age 9 years) 2571 0.04 (−0.04 to 0.10) 0.054 0.03 (−0.02 to 0.09) 0.247 0.05 (−0.02 to 0.11) 0.065 0.04 (−0.02 to 0.10) 0.154 0.02 (−0.03 to 0.08) 0.416
aNot adjusted for in BMI analysis.
bNot adjusted for in HOMA/FPG/FI analysis.
*Indicates p < 0.05.
Table 5. Longitudinal association between DGIH/BMI (age 9) and depressive episode (age 18 years)
Predictor
Odds ratio (95% CI) for depressive episode (age 18 years)
Adjustments
Depressive episode
(18 years) n outcome
Unadjusted model
Demographic adjustments
(sex, birth social class,
ethnicity, maternal
education, maternal EPDS
score)
Lifestyle adjustments
(BMIa, HOMA2
b, physical
activity)
Immune adjustments
[IL-6 (9 years)]
Complete model
(all adjustments)
n OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
2hrGT (age 9 years) 23 313 1.21 (0.95–1.54) 0.235 0.98 (0.73–1.31) 0.891 0.91 (0.60–1.38) 0.641 0.91 (0.60–1.39) 0.651 0.85 (0.55–1.30) 0.427
HOMA2 (age 9 years) 23 313 1.16 (0.86–1.20) 0.387 1.14 (0.75–1.72) 0.538 0.98 (0.74–1.31) 0.896 0.98 (0.74–1.30) 0.893 0.98 (0.83–1.31) 0.977
FPG (age 9 years) 23 313 1.03 (0.90–1.07) 0.446 0.85 (0.55–1.30) 0.442 1.08 (0.73–1.61) 0.693 1.05 (0.69–1.58) 0.830 1.19 (0.78–1.84) 0.678
FI (age 9 years) 23 313 1.10 (0.90–1.21) 0.250 1.01 (0.75–1.34) 0.971 1.01 (0.75–1.33) 0.995 1.02 (0.77–1.34) 0.916 0.97 (0.74–1.33) 0.916
BMI (age 9 years) 170 2571 1.23 (0.76–1.32) 0.687 1.04 (0.98–1.10) 0.127 1.05 (0.98–1.11) 0.058 1.06 (0.97–1.12) 0.060 1.05 (0.98–1.12) 0.070
aNot adjusted for in BMI analysis.
bNot adjusted for in HOMA/FPG/FI analysis.
*Indicates p < 0.05.
6
B
.
I.
Perry
et
al.
https://w
w
w
.cam
bridge.org/core/term
s. https://doi.org/10.1017/S0033291719000308
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core. IP address: 137.205.202.152, on 12 M
ar 2019 at 09:04:18, subject to the C
am
bridge C
ore term
s of use, available at
et al., 2011). These associations were not significant following
demographic and lifestyle adjustments suggesting that the meta-
bolic dysfunction present in depression may be attributable to
sociodemographic and lifestyle factors. Interestingly however,
whilst the CIs became larger (and included the null) after con-
founding adjustments, the point estimates did not change sub-
stantially. Research conducted on larger samples of depressed
patients would therefore be appropriate to increase statistical
power, to further test these findings.
Our findings differ from previous longitudinal research from
the Northern Finland Birth Cohort (NFBC) (Timonen et al.,
2006), which found IR to be cross-sectionally associated with
depressive symptoms even after adjustments for similar confoun-
ders. However, in that study, a different mathematical method, the
Qualitative Insulin Sensitivity Check Index (QUICKI) (Katz et al.,
2000) was used to measure IR. The QUICKI is limited in being
blind to several important physiological aspects of glucose hom-
oeostasis; and being calibrated to an aged insulin assay (Wallace
et al., 2004). We used the computerised, updated HOMA2
model that addresses the shortcomings of QUICKI and other
early models. Additionally, the participants in the Finnish study
were older (age 31 years) thus the potential for confounding by
the potential chronic lifestyle factors of depression was increased.
Another previous study using NFBC data found no association
between depression and the wider metabolic syndrome as a
whole, after controlling for similar adjustments at age 31 years
(Herva et al., 2006). The metabolic syndrome classification may
be less sensitive to early metabolic dysfunction than measures
of IR. For example, a smaller cross-sectional study from Taiwan
of 323 participants (mean age of 19.5 years) found no association
between depression and the metabolic syndrome as a whole, but
did find associations with specific elements of metabolic dysfunc-
tion such as BMI and hypertension, though the associations atte-
nuated following adjustments (Lin et al., 2014). Whilst this latter
study was relatively small, the results are in line with ours.
Another study of young adults from the USA found depression
to be associated with the metabolic syndrome at age 30 years
(Kinder et al., 2004).
We found no associations longitudinally between age 9 mar-
kers of DGIH/BMI and later development of depressive symp-
toms/episode by age 18 years. However, our longitudinal
analyses of glycaemic function were susceptible to reduced statis-
tical power due to the smaller sample that underwent glycaemic
testing at age 9 years in the cohort. Therefore, since the number
of depression events in the longitudinal analyses of glycaemic
function was relatively small, the corresponding demographic
and lifestyle adjustment models may have been susceptible to
model overfit (Peduzzi et al., 1996), limiting the generalisability
of these results. Results for the longitudinal analyses should there-
fore be interpreted with caution.
Taken together, our results suggest that the sociodemographic
and lifestyle features of the depressive syndrome such as gender,
ethnicity, paternal social class, smoking, alcohol use and physical
activity levels may be driving the known associations between
T2DM, obesity and depression. Nonetheless, sensitive metabolic
changes are apparent from a relatively early age. This is an
important finding. Whilst the demographic confounders we
adjusted for are fixed, the lifestyle confounders we adjusted for
may be malleable. For that reason, our results demonstrate the
crucial importance for even relatively young patients diagnosed
with depression to receive a full and comprehensive assessment
of metabolic function. Encouragement and importance should
be placed on encouraging and incentivising positive lifestyle
changes, such as smoking cessation and reducing alcohol intake.
Interestingly, other relevant lifestyle changes such as encouraging
a healthy diet and regular exercise show some evidence for having
intrinsic mood-boosting properties (Jacka et al., 2010; Cooney
et al., 2014).
Strengths and limitations
The ALSPAC cohort provided a relatively large sample size in
which to conduct analyses and we were able to consider detailed
potential confounders including current/recent inflammation,
alcohol use, BMI (in IR analyses), IR (in BMI analyses), smoking,
physical activity, maternal post-natal EPDS score, paternal social
class, ethnicity and sex. We attempted to reduce bias and increase
statistical power (Dong and Peng, 2013) by using the MI method
to account for missing data where possible.
However, there are several limitations that should be consid-
ered. Firstly, we have put emphasis on the effects of lifestyle on
glycaemic and anthropometric parameters, however the lifestyle
data we collected in our analyses was mostly collected via self-
report questionnaires. Self-report questionnaire data on lifestyle
factors can be limited in its validity and reliability, for reasons
such as social desirability or recall bias (Sallis and Saelens, 2000;
Del Boca and Darkes, 2003; Shipton et al., 2009). ALSPAC does
have a quantitative measure for physical activity at age 18 years.
Participants were invited to take part in a week-long wrist accel-
erometer study, however, the sample size that were able to provide
full data on this study was much smaller than data available for
the self-report measure; participants were asked to remove the
accelerometer for certain types of exercise; and, we felt that data
collected in this manner may be susceptible to the Hawthorne
effect. Nonetheless, the limitations of using self-report data for
lifestyle parameters should be taken into account when interpret-
ing our findings.
Due to the significant amount of missing data in our longitu-
dinal analyses, imputing such missing data may have led to both
to selection bias and to type-II statistical error (Lee and Huber,
2011). It is therefore likely our longitudinal analyses, particularly
of glycaemic function, are underpowered. In such analyses, mod-
els including demographic or lifestyle adjustments are likely to be
overfit, limiting their generalisability. Our longitudinal findings
should therefore be interpreted with caution. Selection bias is
also a possibility since not all ALSPAC participants attended vol-
untary CIS-R assessment at age 18. In addition, we have used
paternal social class at birth as a proxy of social class and potential
adversity of the participant and these suppositions may be open to
challenge. Furthermore, whilst most biochemical tests were
sampled in the fasting state, age 9 inflammatory markers were
sampled in the non-fasting state, which may increase measure-
ment error. Measurement error can introduce a bias towards
the null, so the results for IL-6 may be underestimated. Also,
we have examined an a priori hypothesis based upon potential
biological plausibility involving immune dysfunction upstream
of both DGIH and BMI. However, obesity is known to be a
pro-inflammatory state itself (Jung and Choi, 2014), thus reverse
causality may be a possibility. Future research may seek to take
this into account. Additionally, whilst we restricted our analyses
to participants with CRP < 10 mg/L to account for chronic/acute
infection/inflammatory illness, we were unable to ascertain
whether included participants were in receipt of immune-
modulating medications. Finally, whilst we included data for
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IL-6 and CRP, future analyses may seek to examine additional cir-
culating markers of innate and adaptive immune response.
Implications and future directions
Our findings have implications both in the assessment and man-
agement of patients who present with symptoms of depression.
We found that even at the relatively young age of 18 years, depres-
sion is associated with DGIH and raised BMI. That the metabolic
associations with depression can occur at such an early phase of a
potentially chronic course of depression is significant and under-
lines the need for swift and comprehensive assessment and man-
agement of metabolic risk factors in people that present with
depression. Our findings may provide impetus for the monitoring
of more sensitive measures of metabolic function in people first
presenting with depression, since the elements that make up the
‘metabolic syndrome’, of which IR and BMI are a part, are by def-
inition reversible (Alberti et al., 2005), and therefore early inter-
vention may help to attenuate the significant morbidity
(Goldney et al., 2004) and socioeconomic cost (Molosankwe
et al., 2012) associated with comorbid depression and metabolic
dysfunction. Taken together with previous research (Khandaker
et al., 2014; Miller and Raison, 2016; Khandaker et al., 2018a)
which suggests that immune dysfunction could be a target for pre-
vention and treatment of depression, our findings may suggest
that other factors also play an important role in increasing the
physical health burden associated with depression. Impetus
should be placed on encouraging healthy lifestyles such as with
a healthy diet and exercise, which have both shown to be benefi-
cial in improving depression (Schuch et al., 2016a, 2016b;
Teasdale et al., 2017).
Future research should seek to examine associations between
young adults with depression and measures of dyslipidaemia,
which may also be relevant (Parekh et al., 2017), and should seek
to address whether improved recognition and interventions for
modifiable lifestyle factors in the early treatment of depression
may result in more favourable long-term physical health outcomes.
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